These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33993682)

  • 21. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
    Hoffmann M; Mösbauer K; Hofmann-Winkler H; Kaul A; Kleine-Weber H; Krüger N; Gassen NC; Müller MA; Drosten C; Pöhlmann S
    Nature; 2020 Sep; 585(7826):588-590. PubMed ID: 32698190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
    Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study.
    Bhushan B L S; Wanve S; Koradia P; Bhomia V; Soni P; Chakraborty S; Khobragade A; Joshi S; Mendiratta SK; Kansagra KK; Parihar A; Sharma S; Patel J;
    Int J Infect Dis; 2021 Oct; 111():281-287. PubMed ID: 34428542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
    Choi YM; Jeong H; Park U; Cho NH; Kim BJ
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
    Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
    Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience.
    Kamyshnyi A; Koval H; Kobevko O; Buchynskyi M; Oksenych V; Kainov D; Lyubomirskaya K; Kamyshna I; Potters G; Moshynets O
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
    Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells.
    Liu Y; Rao J; Mi Y; Chen L; Feng L; Li Q; Geng J; Yang X; Zhan X; Ren L; Chen J; Zhang X
    Front Immunol; 2022; 13():1008084. PubMed ID: 36389816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro.
    Ziganshyna S; Szczepankiewicz G; Kuehnert M; Schulze A; Liebert UG; Pietsch C; Eulenburg V; Werdehausen R
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
    J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
    Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
    Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lectin from
    Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.
    Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Seibert B; Rajao DS; Wang J; Perez DR
    Sci Rep; 2021 May; 11(1):9609. PubMed ID: 33953295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiviral properties of synthetic histidine derivatives containing membranotropic volumetrical carbocycles in their molecule against SARS-CoV-2 virus
    Garaev TM; Grebennikova TV; Avdeeva VV; Lebedeva VV; Larichev VF
    Vopr Virusol; 2023 Mar; 68(1):18-25. PubMed ID: 36961232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening.
    Rodriguez K; Saunier F; Rigaill J; Audoux E; Botelho-Nevers E; Prier A; Dickerscheit Y; Pillet S; Pozzetto B; Bourlet T; Verhoeven PO
    J Trace Elem Med Biol; 2021 Dec; 68():126818. PubMed ID: 34274845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience.
    Pereda R; González D; Rivero HB; Rivero JC; Pérez A; López LDR; Mezquia N; Venegas R; Betancourt JR; Domínguez RE
    J Interferon Cytokine Res; 2020 Sep; 40(9):438-442. PubMed ID: 32960147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.